The Diverse Roles of Spliceosomal Proteins in the Regulation of Cell Processes
- 作者: Anufrieva K.S.1,2,3, Shender V.O.1,2, Arapidi G.P.1,2,3, Lagarkova M.A.2, Govorun V.M.1,2,3
-
隶属关系:
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Federal Research and Clinical Center of Physical–Chemical Medicine, Federal Medical Biological Agency of the Russian Federation
- Moscow Institute of Physics and Technology (State University)
- 期: 卷 45, 编号 1 (2019)
- 页面: 1-8
- 栏目: Review Article
- URL: https://journals.rcsi.science/1068-1620/article/view/229155
- DOI: https://doi.org/10.1134/S1068162019010035
- ID: 229155
如何引用文章
详细
The spliceosome is necessary for the removal of intron sequences in transcribed pre-mRNA in eukaryotic cells. More than 200 proteins are involved in the process of pre-mRNA splicing; they coordinate the alternative splicing of most eukaryotic genes, which participate in the regulation of a variety of important cellular processes. However, a growing number of studies demonstrate the functions of spliceosomal proteins that are not directly related to the splicing process, such as (1) R-loop formation, (2) DNA repair, (3) telomere elongation, (4) M phase regulation, and (5) mRNA export from the nucleus. In this review, we summarize the data on the noncanonical functions of the spliceosomal proteins. Taking into account the fact that mutations in spliceosomal genes are commonly found in tumor cells, a careful study of noncanonical functions of spliceosomal proteins may provide new insights into the development of effective methods of cancer treatment and design of drugs for delaying cell aging.
作者简介
K. Anufrieva
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Federal Research and Clinical Center of Physical–Chemical Medicine, Federal Medical Biological Agency of the Russian Federation; Moscow Institute of Physics and Technology (State University)
Email: info@pleiadesonline.com
俄罗斯联邦, Moscow, 119779; Moscow, 119435; Dolgoprudnyi, 141701
V. Shender
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Federal Research and Clinical Center of Physical–Chemical Medicine, Federal Medical Biological Agency of the Russian Federation
Email: info@pleiadesonline.com
俄罗斯联邦, Moscow, 119779; Moscow, 119435
G. Arapidi
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Federal Research and Clinical Center of Physical–Chemical Medicine, Federal Medical Biological Agency of the Russian Federation; Moscow Institute of Physics and Technology (State University)
Email: info@pleiadesonline.com
俄罗斯联邦, Moscow, 119779; Moscow, 119435; Dolgoprudnyi, 141701
M. Lagarkova
Federal Research and Clinical Center of Physical–Chemical Medicine, Federal Medical Biological Agency of the Russian Federation
Email: info@pleiadesonline.com
俄罗斯联邦, Moscow, 119435
V. Govorun
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Federal Research and Clinical Center of Physical–Chemical Medicine, Federal Medical Biological Agency of the Russian Federation; Moscow Institute of Physics and Technology (State University)
Email: info@pleiadesonline.com
俄罗斯联邦, Moscow, 119779; Moscow, 119435; Dolgoprudnyi, 141701
补充文件
